Delanzomib

• Description:

  A potent, orally active proteasome inhibitor with IC50 of 3.8 nM against chymotrypsin-like proteasome activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  413.2751

• Molecular Formula:

  C21H28BN3O5

• Notes:

  Research use only, not for human use.

• Receptor:

  Chymotrypsin-likeproteasome

• CAS Number:

  847499-27-8